Who
LSP 7 Cooperative UA
Director and 10% owner
Company insider
Files Form 4 as: Director and 10% owner, Evommune.
In numbers
- Trades disclosed
- 7
- Buys
- 1
- Sells
- 0
- Bought
- $25.0M
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 1
- First trade
- 7 Nov 2025
- Last trade
- 17 Feb 2026
- Last filed
- 19 Feb 2026
Companies traded
Activity over time
1 Nov 2025 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 17 Feb 2026filed 19 Feb 2026 | EVMN EvommuneBiotechnology | SEC FORM 4 Code A | $10.0M358,680 at $27.88 | filing |
| 17 Feb 2026filed 19 Feb 2026 | EVMN EvommuneBiotechnology | SEC FORM 4 Code A | $10.0M358,680 at $27.88 | filing |
| 7 Nov 2025filed 12 Nov 2025 | EVMN Evommuneoption or derivative · Biotechnology | SEC FORM 4 Code C | —15,493,466 | filing |
| 7 Nov 2025filed 12 Nov 2025 | EVMN Evommuneoption or derivative · Biotechnology | SEC FORM 4 Code C | —5,090,000 | filing |
| 7 Nov 2025filed 12 Nov 2025 | EVMN Evommuneoption or derivative · Biotechnology | SEC FORM 4 Code C | —6,585,011 | filing |
| 7 Nov 2025filed 12 Nov 2025 | EVMN EvommuneBiotechnology | SEC FORM 4 Code C | —3,367,133 | filing |
| 7 Nov 2025filed 12 Nov 2025 | EVMN EvommuneBiotechnology | SEC FORM 4 Bought | $25.0M1,562,500 at $16.00 | filing |
News
Evommune (NYSE:EVMN) Stock Bumped Up to "Hold" by UBS GroupEVMN · tickerreport.com · 14 Oct 2026Evommune (NYSE:EVMN) Upgraded at UBS GroupEVMN · dailypolitical.com · 14 Oct 2026
0 headlines in the last 90 days name LSP 7 Cooperative UA; 2 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.